Atomoxetine Titration Week by Week: What to Expect on Strattera
A week-by-week guide to atomoxetine (Strattera) titration for ADHD — the 4–8 week onset timeline, side effects, CYP2D6, and when to switch or combine.
Get new titration guides by email
Occasional, evidence-based guides on medication tracking and titration — no noise.
Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or a prescription recommendation. All medication decisions must be made by you and your licensed healthcare provider based on your individual medical history and circumstances. The dosing ranges cited are drawn from FDA prescribing information and clinical guidelines (NICE NG87, CADDRA); your prescriber may follow a different plan appropriate to your specific needs.
Atomoxetine — sold under the brand name Strattera in the US and other markets — is the most widely studied non-stimulant medication for ADHD. It works very differently from stimulants: no same-day effect, no peak or crash, and no controlled-substance scheduling. For the right person, it provides steady 24-hour coverage without the appetite suppression, insomnia, or rebound that stimulants can cause.
The trade-off is patience. Atomoxetine takes 4–8 weeks to reach full effect, and the early weeks can feel slow or discouraging. This guide explains the week-by-week timeline, what to expect, what to log, and how to avoid the most common mistake: stopping too early.
For a broader comparison of non-stimulant options, see our complete guide to non-stimulant ADHD medications.
How atomoxetine works
Atomoxetine is a selective norepinephrine reuptake inhibitor (NRI). It increases norepinephrine levels in the prefrontal cortex, the brain region responsible for executive function, attention regulation, and impulse control. Unlike stimulants, it does not significantly increase dopamine in the nucleus accumbens (the reward center), which is why it has little to no abuse potential [1].
Because it works through gradual receptor adaptation rather than acute neurotransmitter flooding, the therapeutic effect builds slowly. This is a feature, not a bug — but it requires a different mindset than stimulant treatment.
Atomoxetine dosing and titration schedule
Atomoxetine is available in capsules of 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, and 100 mg. The standard adult dosing schedule per FDA prescribing information is:
- Starting dose: 40 mg once daily for a minimum of 3 days
- Target dose: 80 mg once daily
- Maximum dose: 100 mg once daily if needed and tolerated
- Divided dosing: The total daily dose can be split into morning and late-afternoon doses if side effects are problematic
Some prescribers start at a lower dose (e.g., 25 mg or 10 mg) for people who are sensitive to medications or have anxiety. The dose can be increased by 20–40 mg per week, or more slowly if side effects are present [2].
| Week | Typical adult dose | What to expect |
|---|---|---|
| Week 1 | 10–40 mg once daily | Tolerability check; no meaningful ADHD benefit yet |
| Week 2 | 40 mg once daily | Early side effects (nausea, fatigue, dry mouth) may appear; benefits still minimal |
| Week 3 | 60–80 mg once daily | First subtle improvements in attention or impulse control may emerge |
| Week 4–6 | 80 mg once daily | Gradual build of effect; benefits become clearer |
| Week 8+ | 80–100 mg once daily | Full therapeutic effect; dose adjustments based on response and tolerability |
Week 1 — starting dose: tolerability only
At 10–40 mg, you are very unlikely to feel any ADHD improvement. This week is purely about checking whether your body tolerates the medication. The most common early side effects are:
- Nausea or stomach upset (often improves with food)
- Fatigue or drowsiness
- Dry mouth
- Mild headache
- Decreased appetite (less severe than stimulants)
What to log:
- Time you took the dose
- Any side effects and their severity (1–5)
- Sleep quality
- Appetite and meals
- Any anxiety or mood changes
If side effects are severe, contact your prescriber. Mild side effects usually improve over the first 2 weeks.
Week 2 — early effects: mostly side effects
Many people find week 2 to be the hardest part of atomoxetine titration. Side effects are still present, but the benefits are not yet visible. This is the window where premature discontinuation is most common — and most often a mistake.
Why this happens: atomoxetine needs to reach steady-state blood levels and then produce downstream receptor changes before clinical effects emerge. This takes time.
What to log:
- Same side-effect checklist as week 1
- Any subtle changes in attention, impulse control, or emotional regulation (even if uncertain)
- Sleep quality and timing
- Energy levels throughout the day
If nausea is severe, taking the dose with food or splitting it into two doses can help. Some people prefer taking the full dose at night because the sedation can be leveraged for sleep.
Week 3 — first subtle benefits
By week 3, some people notice the first hints of improvement. These are usually subtle and may include:
- Slightly easier task initiation
- Less internal restlessness
- A quieter mental background
- Better tolerance for boring or repetitive tasks
- Slightly improved emotional regulation (less reactive)
These effects are not dramatic. They are often best detected by comparing specific behaviors week over week rather than by overall mood.
What to log:
- Functional tasks: did you complete more work tasks? Were you on time more often?
- Social interactions: fewer interruptions? Less frustration?
- Emotional regulation: fewer irritable outbursts? Less overwhelm?
- Side effects: are they improving or worsening?
Week 4–6 — effect builds
This is where atomoxetine begins to differentiate itself from a placebo for most responders. By week 4–6, the benefits should be clearer:
- More consistent focus across the day
- Less need for external pressure to start tasks
- Better working memory in daily life
- Reduced impulsivity in conversations and decisions
- More stable emotional tone
If you have reached 80 mg by this point and still feel nothing, your prescriber may:
- Continue to 10–12 weeks (some people respond later)
- Increase to 100 mg/day
- Consider that you may be a non-responder and discuss alternatives
The evidence supports waiting at least 4–6 weeks at a stable therapeutic dose before judging atomoxetine ineffective [3].
Week 8+ — full therapeutic effect and maintenance
By week 8, most responders have a clear picture of atomoxetine's effect. At this stage, the question is:
- Is the benefit strong enough to continue?
- Are side effects manageable?
- Do I need a higher dose (up to 100 mg) or a lower dose?
- Would combining with a stimulant help?
Combination therapy (atomoxetine + a stimulant) is evidence-supported for some patients, particularly those who get partial benefit from atomoxetine alone but need more coverage or faster onset during the day [4]. This should only be done under prescriber supervision.
Atomoxetine side effects and management
| Side effect | Typical timing | Management |
|---|---|---|
| Nausea / GI upset | Weeks 1–2 | Take with food; split into two doses |
| Fatigue / sedation | Weeks 1–3 | Take at night; usually improves |
| Dry mouth | Ongoing | Hydration, sugar-free gum |
| Decreased appetite | Mild, ongoing | Smaller, frequent meals |
| Sexual side effects | Weeks 2–8+ | Erectile dysfunction, decreased libido (more common in men) — discuss with prescriber |
| Increased heart rate / BP | Ongoing | Mild pressor effect; monitor home BP/HR |
| Mood changes | Rare but serious | Report suicidality or severe agitation immediately |
Atomoxetine carries a black-box warning for suicidal ideation in children and adolescents. Adults should also report any new or worsening mood symptoms, suicidal thoughts, or severe agitation to their prescriber immediately [5].
CYP2D6: the genetic factor that changes your dose
Atomoxetine is metabolized by the liver enzyme CYP2D6. People fall into different metabolizer categories:
- Normal metabolizers — standard dosing works as expected
- Poor metabolizers — process atomoxetine slowly; may have higher side effects at standard doses and may need lower doses
- Ultra-rapid metabolizers — process atomoxetine quickly; may have reduced efficacy at standard doses
Your prescriber may order genetic testing if you have unusual side effects or no response at standard doses. Some medications (like fluoxetine/paroxetine, certain antidepressants) strongly inhibit CYP2D6 and can raise atomoxetine levels.
Atomoxetine vs. stimulants: when to choose which
| Factor | Atomoxetine | Stimulants |
|---|---|---|
| Onset | 4–8 weeks | Same day |
| Duration | 24/7 | 4–12 hours per dose |
| Peak/crash | None | Present, varies by formulation |
| Appetite | Mild or neutral | Often significantly suppressed |
| Sleep | Often neutral or improving | Can disrupt sleep |
| Anxiety | Often neutral or improving | Can worsen anxiety |
| Substance abuse risk | Low | Higher (Schedule II) |
| Convenience | Once daily | Once or multiple times daily |
| Effect size | Moderate | Larger (on average) |
Atomoxetine is often a good choice for people with co-occurring anxiety, a history of substance use disorder, or difficulty tolerating stimulant side effects. It is also sometimes used as an adjunct to a stimulant for 24-hour coverage.
Track your atomoxetine titration with Titrate
Atomoxetine's slow onset makes memory-based reporting especially unreliable. You may not remember whether your focus was slightly better in week 3 or week 5, and your prescriber needs that granularity to decide whether to continue, increase, or switch.
Titrate is designed for this. Daily check-ins track dose, side effects, sleep, and functional markers. Over 4–8 weeks, the data shows whether the gradual effect is real — and gives your prescriber a clear basis for the next decision.
→ Start tracking your atomoxetine titration free ← → See how prescribers view Titrate reports ←
Also see our complete guide to non-stimulant ADHD medications and stimulant titration timelines.
FAQ
Q: What if I feel nothing for the first 3 weeks? That's normal. Atomoxetine does not work like a stimulant. Most people need 4–6 weeks at a stable dose to see a clear effect. The biggest mistake is stopping at week 2 because it "doesn't work."
Q: Can I take atomoxetine only on days I need to focus? No. Atomoxetine needs to be taken every day to maintain steady levels and produce its therapeutic effect. It is not a PRN (as-needed) medication.
Q: Can I drink coffee while taking atomoxetine? Caffeine is generally less problematic with atomoxetine than with stimulants, but it can still increase heart rate and anxiety. Keep your intake consistent so your data isn't confounded.
Q: Can atomoxetine be taken at night? Yes, and many people prefer it because early sedation can help with sleep. However, some people find it activating. Work with your prescriber to find the best time.
Q: Can I take atomoxetine with stimulants together? Yes, this is a common combination strategy when a stimulant provides daytime coverage but atomoxetine is needed for 24-hour effect, emotional regulation, or anxiety management. Never combine medications without prescriber supervision.
Q: What are the most serious side effects? Seek urgent medical help if you experience severe chest pain, shortness of breath, fainting, severe agitation, hallucinations, or suicidal thoughts. Report new or worsening mood symptoms to your prescriber promptly.
Q: Does atomoxetine work as well as stimulants? On average, stimulants have larger effect sizes in clinical trials. However, "average" doesn't matter for an individual. For some people, atomoxetine is the better medication because of fewer side effects, no rebound, or better fit with their co-occurring conditions.
Key takeaways
- Atomoxetine (Strattera) is a non-stimulant NRI that takes 4–8 weeks to reach full effect.
- The first 2 weeks are about tolerability, not benefit. Stopping too early is the most common mistake.
- Standard adult dosing starts at 40 mg and targets 80 mg, with 100 mg as the maximum.
- Side effects are usually milder than stimulants and often improve with food, dose timing, or slower titration.
- CYP2D6 metabolism affects response — poor and ultra-rapid metabolizers may need dose adjustments.
- Atomoxetine is often a good choice for people with anxiety, substance use history, or stimulant intolerance.
- Structured tracking is essential because the effect is gradual and easy to miss from memory alone.
References
- Michelson D, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53(2):112–120.
- Strattera (atomoxetine) — FDA Prescribing Information. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021411s027lbl.pdf
- Biederman J, et al. A systematic review of the efficacy and safety of atomoxetine for the treatment of pediatric and adult ADHD. J Clin Psychiatry. 2022;83(1):21r13896.
- Wilens TE, et al. A pilot study of guanfacine ER in combination with a psychostimulant for the treatment of ADHD. J Atten Disord. 2011;15(3):209–217.
- Bangs ME, et al. Meta-analysis of suicide-related behavior or ideation in placebo-controlled clinical trials of atomoxetine. J Child Adolesc Psychopharmacol. 2014;24(9):477-484.
- Cortese S, et al. Comparative efficacy and tolerability of medications for ADHD: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738.
This article is for educational purposes only. It does not constitute medical advice. Always consult your licensed healthcare provider about medication decisions.